Low-dose chemotherapy for extra-abdominal desmoid tumor.

Area of Science:

• Oncology
• Medical Research

Background:

• Desmoid tumors, though rare, can cause significant morbidity.
• Extra-abdominal desmoid tumors present unique treatment challenges.
• Low-dose chemotherapy is explored as a therapeutic option.

Purpose of the Study:

• To evaluate the efficacy of low-dose chemotherapy (methotrexate and vinblastine) for extra-abdominal desmoid tumors.
• To assess tumor response and treatment-related toxicity in patients with desmoid tumors.
• To determine the impact of chemotherapy on patient symptoms and quality of life.

Main Methods:

• Retrospective review of 12 patients with extra-abdominal desmoid tumors treated between 1996-2003.
• Weekly administration of low-dose methotrexate and vinblastine.
• Evaluation of tumor response, symptom relief, functional improvement, and treatment toxicity.

Main Results:

• Partial response or stable disease observed in all patients (6 partial response, 6 stable).
• Significant symptom relief reported in 6 of 7 patients with painful tumors.
• Treatment-related toxicities were common, though generally manageable; peripheral neuropathy was the main long-term side effect.

Conclusions:

• Low-dose chemotherapy is an effective strategy for managing extra-abdominal desmoid tumors.
• This treatment modality helps prevent local disease progression.
• Chemotherapy significantly improves patient symptoms and functional outcomes.